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Abstract 
Background: Allergic rhinitis (AR) is the most common allergic disorder and its prevalence 1 
has significantly increased worldwide, nowadays affecting up to 40% of the population in 2 
young adults. The objective of the present survey was to evaluate the prevalence of allergic 3 
sensitization and the prevalence of clinically diagnosed AR in a sample of the Belgian 4 
population, and to estimate the effect of age and gender. 5 
Methods: We performed a cross-sectional population-based study on an annual public fair in 6 
Ghent. Participants underwent a skin prick test (SPT) to 3 aeroallergens: mix of trees (hasel, 7 
alder, birch), grass pollen and house dust mite (HDM). The clinical relevance of sensitization 8 
was assessed by relating relevant symptoms of AR to the corresponding SPT. 9 
Results: 2320 participants (1475 females, median age of 44.7 years, range 3y-86y) were 10 
included in this study. Standardized prevalence rates of sensitization were 13.2% for tree mix, 11 
25.9% for grass pollen and 25.9% for HDM. Sensitization to at least one of the allergens was 12 
present in 40.3% of the subjects. Symptomatic sensitization related to trees was reported in 13 
9.7%, grass related AR was 17.6% and HDM related AR 17.1%. The overall prevalence of 14 
AR was 30.9%. 15 
Conclusion: In this study we demonstrated a 40.3% prevalence of a positive SPT to one or 16 
more common aeroallergens. A clinical diagnosis of AR was present in 30.9%, peaking in the 17 
third and fourth decade of life. It is to be expected that in the next decades, when this 18 
generation will grow older, the general AR prevalence will further increase. 19 
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Introduction 20 
Allergic rhinitis (AR) is the most prevalent form of non-infectious rhinitis, inflammation of 21 
the mucous lining of the nose. Symptoms of AR include rhinorrhea, congestion, nasal itching 22 
and sneezing. This type of rhinitis is caused by an IgE-mediated reaction to environmental 23 
allergens such as house dust mite (HDM), and pollen from grass and trees (1). 24 
Allergic rhinitis poses a considerable burden on public health because of its prevalence, 25 
impact on quality of life, productivity, economic costs and asthma comorbidity (1-3). It 26 
represents a growing global health problem, nowadays affecting up to 40% of the population 27 
(2). Despite the widely recognized burden of allergy, there is insufficient data on the 28 
epidemiology of allergic rhinitis (1). A wide variety between countries in prevalence of 29 
sensitization can be observed (2). Most population-based epidemiologic studies define 30 
allergic rhinitis based on questionnaires with varying diagnostic criteria (4-6). There is a clear 31 
lack of epidemiological studies, reporting a clinical diagnosis of allergic rhinitis in the general 32 
population.  33 
Skin prick testing (SPT) is the standard of care in diagnosing IgE mediated allergy. However, 34 
not all rhinitis patients have a positive SPT, and not all patients with a positive SPT perceive 35 
allergic symptoms (7). Few studies report SPT prevalence in an unselected population-based 36 
sample. 37 
The objective of the present survey was to evaluate the prevalence of allergic sensitization 38 
and the prevalence of clinically diagnosed AR in a population-based sample of the Belgian 39 
population at an annual public fair, and to evaluate the effect of age and gender on 40 
sensitization and presence of symptoms in sensitized subjects. 41 
42 
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Methods 43 
Study design 44 
The study was designed as a cross-sectional population-based study. Subjects were sampled 45 
from visitors of an annual public fair in September 2008 in the city of Ghent, Belgium. Here, 46 
we organized a stand about allergic disease, and visitors were invited to undergo a SPT by 47 
means of visual information about allergic disease. Subjects were required to understand the 48 
procedure and gave oral consent. The study is approved by the local ethical comite. 49 
SPT was performed by otolaryngologists, dermatologists and allergy nurses. The used 50 
allergen panel consisted of a tree mix (hasel, alder, birch), grass pollen mix (Phleum, 51 
Dactylis) and Dermatophagoides pteronyssinus, each at a concentration of 100 I.R./mL (ALK 52 
Abello, Horsholm, Denmark). Histamine and saline were used as positive and negative 53 
control. Each subject was tested on the forearm using stainless steel lancets (ALK Abello, 54 
Horsholm, Denmark). After 15 minutes, the size of each wheal was documented as the mean 55 
of the longest diameter and the longest diameter perpendicular to it. A positive reaction was 56 
defined as a mean wheal size of at least 3 mm, after subtraction of the negative control.  57 
Subjects having a positive SPT were questioned about symptoms (watery anterior 58 
rhinorrhoea, sneezing, nasal obstruction) and in which months these occur. Next, the 59 
examiner evaluated whether the subjects’ symptoms were related to the sensitizations found 60 
in the SPT. For each allergen, symptoms were coded by the examiner as 'no relevant 61 
symptoms', 'current relevant symptoms', 'past relevant symptoms', or 'unknown symptoms'. 62 
Allergy was considered symptomatic when at least one of the symptoms was present, 63 
corresponding allergen exposure with its seasonal pattern (perennial for HDM, seasonal for 64 
grass or tree pollen; specific pollen seasons were provided by local pollen monitoring 65 
agencies). No strict diagnostic criteria were applied, and diagnosis based on clinical history 66 
and SPT was made by the examiner. 67 
6 
 
 68 
Statistical analysis 69 
As over 80% of the public fair visitors were originating from the region of Flanders, Belgium, 70 
prevalences were weighted for age and sex to the Flemish reference population (8) using 71 
direct standardization. Standardized prevalences were estimated using intervals based on Fay 72 
and Feuer (9). Logistic regression, weighted for age and sex, was used to estimate risks of age 73 
and sex for each outcome. All reported odds estimates were mutually adjusted. P-values less 74 
than 0.05 were seen to indicate statistical significance. Missing data were considered to be 75 
missing completely at random. All statistical analyses were carried out using STATA v.11.1 76 
(StataCorp, College Station, TX, USA) with the DISTRATE module for direct 77 
standardization (10). 78 
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Results 79 
Population characteristics 80 
In total, 2320 participants, who all underwent SPT, were included in this study. The group 81 
consisted of 1475 females (63.6%) and had a median age of 44.7 years (range 3-86 y, IQR 82 
26–62 y). Compared to the Flemish reference population, there were slightly more women 83 
and older aged subjects.  84 
 85 
Prevalence of sensitization 86 
Table 1 shows unstandardized and age and sex standardized prevalence rates of sensitization. 87 
Standardized prevalence rates of sensitization were 13.2% for tree mix, 25.9% for grass 88 
pollen, and 25.9% for HDM. Sensitization to at least one of the allergens was present in 89 
40.3%. 90 
We estimated the effect of age and sex on sensitization (Table 2 and Figure 1). Compared to 91 
women, men had an increased rate of sensitization to HDM (p=0.001) and a tendency towards 92 
an increased rate of grass sensitization (p=0.074), but not for trees (p=0.115). For all 93 
allergens, there was an increase in sensitization in the third and fourth age decades, compared 94 
to first two decades. In women, sensitization prevalence peaked between the age of 20 and 29 95 
at 58.3% (95% CI: 51.9%-64.8%), while in men, the highest prevalence of 60.9% (95% CI: 96 
50.7-71%) was found in those aged 30-39 years old. After this peak, the prevalence decreased 97 
with increasing age in both sexes (test for trend p<0.001). 98 
 99 
Prevalence of symptomatic sensitization 100 
The majority of subjects provided information on allergy related symptoms. Of all subjects, 101 
57 did not provide answers to the questions about sensitization to trees, 75 to grass pollen, and 102 
80 to HDM. Because few people answered 'past relevant symptoms' (tree mix: 0, grass pollen: 103 
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5, HDM: 6) and 'unknown symptoms' (tree mix: 16, grass pollen: 42, HDM: 47), these 104 
answers were excluded from analysis. 105 
Symptomatic sensitization (AR) related to trees was reported in 9.7% (Table 1). Grass-related 106 
AR was reported in 17.6% and HDM-related AR in 17.1%. The overall prevalence of AR 107 
(sensitization and relevant symptoms) was 30.9%. There were no significant sex differences 108 
in prevalences of allergen-specific symptomatic sensitizations, but overall prevalence of AR 109 
was more prevalent in men compared to women (p=0.023). The age pattern of AR closely 110 
resembled the pattern of sensitization (Table 2 and Figure 1). 111 
 112 
Symptom presence in sensitized subjects 113 
In those with a positive SPT to tree mix, 81.1% (95% CI: 75.0%-87.3%) experienced nasal 114 
symptoms, while 73.1% (67.5-78.7%) of grass-sensitized and 72.8% (68.5-77.2%) of HDM-115 
sensitized subjects experienced nasal symptoms. Overall, 81.0% (77.8-84.1%) of sensitized 116 
subjects had nasal symptoms. 117 
In sensitized subjects, we estimated the effect of age, sex, and wheal size on symptom 118 
presence using logistic regression (Table 3). Men were less likely to report symptoms in those 119 
sensitized to grass (OR 0.51; p=0.042) and to HDM (OR 0.58; p=0.035) but not in those 120 
sensitized to trees (OR 0.81; p=0.642). There was no effect of age on symptom presence. An 121 
increased wheal size was associated with the presence of symptoms in grass sensitized (OR 122 
1.16 per mm increase; p=0.008) and HDM sensitized (OR 1.26; p<0.001) subjects, but not in 123 
tree sensitized subjects (OR 1.82; p=0.115). In those sensitized to any allergen, we tested the 124 
effect of age, sex and number of sensitizations on the presence of symptoms. There was no 125 
association of symptom presence with age (p for trend=0.63) or sex (p=0.108). The number of 126 
sensitizations strongly increased the presence of symptoms (OR 2.26, p=0.001 for 2 vs 1 127 
sensitization; OR 3.06, p=0.01 for 3 vs. 1 sensitization; test for trend p<0.001). 128 
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 129 
Sensitization patterns 130 
Sensitization prevalences to only one allergen group were 2.8% (95% CI: 2.1-3.5%) for tree 131 
mix, 7.8% (6.5-9.0%) for grass pollen and 10.7% (9.3-12.1%) for HDM.  132 
We compared the observed prevalence of sensitization to different allergen groups to the 133 
prevalence that was expected if a combination would occur by chance alone (Table 4). 134 
Expected prevalences were calculated as the product of the prevalences of sensitizations to 135 
one single allergen group. All combinations had a prevalence that was significantly higher 136 
than expected. Among combinations of two allergen groups, the combination grass pollen and 137 
tree mix showed the highest observed/expected ratio of 18.3, and the ratio of sensitization to 138 
all three allergen groups was 229.5 times the expected prevalence. 139 
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Discussion 140 
We evaluated the prevalence of allergic sensitization and AR symptoms in a population-based 141 
sample of 2320 subjects attending a public fair in the region of Flanders, Belgium. The 142 
adjusted prevalence of sensitization was 13.2%, 25.6% and 25.9% for tree pollen, grass 143 
pollen, and HDM respectively. Globally, 40.3% was sensitized to one or more of the tested 144 
aeroallergens. Men were more allergic than women, especially to HDM. Allergy increased at 145 
young age to reach a maximum between 20-40 years and decreased later in life. In sensitized 146 
subjects, we evaluated the prevalence of AR using a clinical symptom-based diagnosis. The 147 
majority of the sensitized patients (81%) reported allergic symptoms, resulting in a 148 
standardized prevalence of 30.9% for AR. 149 
 150 
Our study provides new insights into the epidemiology of allergic sensitization and AR. 151 
Given the high prevalence of allergy, it is surprising that there is only a limited amount of 152 
data on prevalence of sensitization versus AR symptoms. Most studies assessed AR 153 
prevalence by questionnaire (4-6), using varying diagnostic criteria to define presence of AR, 154 
most of which have not been validated against a gold standard diagnosis (11). Some studies 155 
subsequently included a clinical phase in positive subjects only (2), in which SPT was done. 156 
In contrast, we evaluated SPT in the general population and identified AR patients using a 157 
clinical symptom-based diagnosis. Our assessment of AR closely resembles a gold standard 158 
diagnosis of history taking, clinical examination and allergy testing; this study is unique in 159 
applying a clinical diagnosis to the general population. 160 
 161 
It is difficult to compare our data with earlier results. Most recent studies had some sampling 162 
limitation in terms of age, geographical coverage or comorbidity. Bauchau and Durham (2) 163 
assessed the prevalence of AR among European adults by means of telephone interviews and 164 
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subsequent clinical and IgE-specific confirmation of the positively screened subjects. They 165 
found an overall European prevalence of 22.7%, while the Belgian rate was 28.5%. This is 166 
highly consistent with the prevalence found in the current study, which is 30.9%. A higher 167 
difference could be expected because we also included children, but Bauchau et al. tested for 168 
more allergens. The Belgian region of Antwerp participated in the ECRHS (5) and ISAAC (6) 169 
studies, and a prevalence of AR was found to be 20.9 to 25.1% in the 20-44 year age group, 170 
5.8% in the 6-7 year olds and 16.9% in 13-14 year olds. In a survey, conducted by Bachert et 171 
al. (4), an AR prevalence of 29.8% was found in a representative Belgian population. 172 
 173 
The overall prevalence of positive SPT was 40.3%. Sensitization to the individual allergens 174 
was 25.9% to HDM, 25.6% to grass pollen, and 13.2% to tree mix. An ECRHS study (12) 175 
reported a prevalence of 25.5% sensitized to HDM, 12.2% to timothy grass, 6.9% to birch, 176 
and 34.1% overall in 20-44 year aged subjects. Our data of this age group were higher than 177 
the percentages mentioned above, and might reflect differences in sampling methodology and 178 
the used allergen panel.  179 
According to previous literature, 90.5% of all Belgian sensitized subjects could be revealed 180 
by testing with the three most prevalent allergens (house dust mite, grass mix, birch) (13). 181 
Assuming that our sample was comparable to that of the aforementioned study, extending the 182 
number of allergens tested to 9 would theoretically increase our estimates of overall 183 
sensitization by 10%.  184 
 185 
We found an increase in allergy at young age to reach a maximum in the third and fourth 186 
decade and a decrease in later life. A large review of the available literature about the 187 
epidemiology of AR showed that its prevalence has increased over the last decades, in 188 
particular in countries with low prevalence (14). The interaction between genetic and 189 
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environmental factors seems to be crucial. However, lifestyle changes such as westernization, 190 
urbanization and affluence recently received more attention (15). Consequently, it is to be 191 
expected that the worldwide prevalence of atopy and AR will further grow. On the other 192 
hand, the increase in the number of AR patients seems to recede in countries with high 193 
prevalence (14). In western countries, we still might expect an increase in the general AR 194 
prevalence, because the present 20-40 year old generation will grow older in the next decades, 195 
while a substantial proportion, but probably not longer or only restrictedly growing, of young 196 
children will have AR. 197 
 198 
We observed a higher prevalence of HDM sensitization in men. These results are consistent 199 
with the observation that positive SPTs, especially for HDM, are more prevalent in young 200 
boys than girls (16). A change to female predominance is seen in adolescence (17,18), which 201 
is also seen in our study. In contrast with previous reports (19), we found a significantly 202 
higher prevalence of overall SPT positivity in men. This gender difference in our study was 203 
largely attributed by differences in HDM sensitization. Indeed, HDM sensitization has been 204 
reported to be predominantly present in male persons, both children and adults (20). 205 
 206 
Because the clinical relevance of a positive SPT often is uncertain, we also assessed the 207 
presence of allergy symptoms in relation to allergen exposure. Four out of five sensitized 208 
subjects experienced symptoms of AR. This number is consistent with results of Burbach et 209 
al. (7), who studied clinical relevance of SPTs based on Global Asthma and Allergy European 210 
Network (GA(2)LEN) data. Interestingly, skin prick test-positive subjects without symptoms 211 
are at risk to develop allergic symptoms (21). However, by thorough exploration of the 212 
clinical history, Assing et al. (22) showed that of these asymptomatic subjects developing 213 
symptoms, the majority had already had symptoms before inclusion or even denied 214 
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symptoms. When history and SPT do not match, a thorough history exploration combined 215 
with a symptom diary could demonstrate additional AR patients. 216 
 217 
We analyzed risk factors for having AR symptoms in those who were sensitized. The number 218 
of sensitizations strongly predicted symptom presence, which is in line with previous 219 
observations (7). When having a positive SPT for grass pollen or HDM, women were 220 
significantly more prone to experience symptoms than men. This is in sharp contrast with the 221 
prevalence of sensitization, which was more common in men. This disparity was also 222 
observed in a meta-analysis, showing HDM sensitization to be more prevalent in men, but 223 
allergic airway symptoms tending to show a female predominance (20). 224 
 225 
Another predicting factor of symptom presence is the wheal size of the SPT. When the wheal 226 
size of HDM and grass pollen allergens increased, there was a significantly higher risk of 227 
experiencing AR symptoms. A quantification of atopy by means of reporting IgE levels and 228 
skin test diameters has already been proposed because of the positive correlation of higher 229 
values with the probability of rhinitis (23). However, we have to take into account the 230 
contribution of psychological factors to patient perception of allergy symptoms. In some 231 
studies, no correlation between symptom severity and age or sex, nor wheal size could be 232 
found, but some behavior traits could partly explain symptom reporting (24). 233 
 234 
We analyzed the prevalence of sensitization to different allergen groups (grass pollen, tree 235 
mix and HDM), and compared this to the expected prevalences (based on prevalence of 236 
sensitization to the single allergen groups). All possible combinations of allergen groups 237 
occurred more frequently than chance alone would suggest, indicating that sensitizations do 238 
not occur independently. These results indicate evidence for the concept of atopy as a 239 
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constitution. Previous studies showed that polysensitization is very common in the European 240 
general population (25). Moreover, a large group of monosensitized children developed 241 
additional sensitizations at older age (26). Possible explanations are a defect in the epithelial 242 
barrier, and the IL-4 promotion of TH2 differentiation, which might be responsible for the 243 
observation that sensitization to one allergen can enhance systemic and airway TH2 responses 244 
to a second allergen (27). A recent study concluded that children remaining monosensitized, 245 
showed a significantly higher production of IL-10 and IFN-γ, both involved in the T-246 
regulatory cell/TH1 cascade (28). Furthermore we observed that in sensitizations to two 247 
allergen groups, the risk ratio of grass pollen and tree mix was higher than combinations with 248 
HDM, which is in line with findings that HDM showed the highest rate of monosensitization 249 
(29). 250 
 251 
We must interpret the results of this study with care. A selection bias is possible, due to the 252 
spontaneous entry of visitors. Allergy sufferers showing a higher interest in participation 253 
could cause overestimation, although those with a known diagnosis could show decreased 254 
interest as well. Moreover, the population visiting an annual fair could be biased by age, sex 255 
and socio-economic factors. Women and 60 to 69-year-olds were slightly overrepresented, 256 
which we eliminated by standardization. Lastly, our study was carried out in September, 257 
possibly impacting the prevalence of symptomatic grass allergy differently than other 258 
allergens due to recall bias. 259 
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Conclusion 269 
In this population-based cross-sectional study, we demonstrated a 40.3% prevalence of a 270 
positive SPT to one or more common aeroallergens. A clinical diagnosis of allergic rhinitis 271 
was present in 30.9%. This study does not only show sensitization and rhinitis symptoms, but 272 
links those for each individual allergen, demonstrating that 80% of subjects have symptoms 273 
related to the individual SPT results, with no large difference between allergens. Both a 274 
positive SPT and AR peak in the third and fourth decade of life. It is to be expected that in the 275 
next decades, when this generation will grow older, the general AR prevalence will further 276 
increase. 277 
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Figures 365 
Figure 1: Age and gender differences of sensitization and allergic rhinitis. 366 
Graphical representation of age and gender differences in positive skin prick tests (lines, black 367 
box line = female, white box line = male) and symptomatic sensitization (AR; bars, black bar 368 
graph = female, white bar graph = male). (A) Tree pollen; (B) House dust mite; (C) Grass 369 
pollen; (D) At least one allergen. 370 
371 
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Tables 372 
Table 1: Unstandardized and age and sex standardized prevalence rates of sensitization 373 
(defined by positive skin prick test) and allergic rhinitis (defined by positive skin prick test 374 
with symptoms). 375 
Outcome cases n Crude  prevalence 
Standardized 
prevalence 95% CI 
sensitization       
 tree mix 316 2317 13,6% 13,2% 11,7% 15,0% 
 grass mix 555 2320 23,9% 25,6% 23,3% 28,0% 
 HDM 564 2318 24,3% 25,9% 23,6% 28,3% 
 any sensitization 887 2317 38,3% 40,3% 37,5% 43,3% 
       
sensitization + 
symptoms of AR    
 tree mix 223 2263 9,8% 9,7% 8,3% 11,2% 
 grass mix 370 2245 16,5% 17,6% 15,7% 19,7% 
 HDM 367 2240 16,4% 17,1% 15,2% 19,1% 
 any allergic rhinitis 656 2236 29,3% 30,9% 28,4% 33,6% 
